Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension

Published:2018-07-25 Issue:12 Volume:31 Page:1324-1331
ISSN:0895-7061
Container-title:American Journal of Hypertension
language:en
Short-container-title:

Author:

Hwang Andrew Y¹^ORCID,Dave Chintan V²,Smith Steven M³⁴

Affiliation:

1. Department of Clinical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, North Carolina, USA

2. Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA

3. Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida, USA

4. Department of Community Health and Family Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA

Funder

National Academy of Medicine

National Heart, Lung, and Blood Institute

Publisher

Oxford University Press (OUP)

Subject

Internal Medicine

Link

http://academic.oup.com/ajh/article-pdf/31/12/1324/26555463/hpy118.pdf

Reference29 articles.

1. Potential U.S. population impact of the 2017 ACC/AHA high blood pressure guideline;Muntner;J Am Coll Cardiol,2018

2. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries;Mills;Circulation,2016

3. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators;Staessen;Lancet,1997

4. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group;JAMA,1991

5. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification;Ogden;Hypertension,2000

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting From 2006 to 2016;The Journal of Pain;2023-11

2. Analysis and forecast of emergency medical care indicators for patients with diseases characterized by high blood pressure;EMERGENCY MEDICAL CARE;2023-06-01

3. THE ALGORITHM FOR THE TREATMENT OF PATIENTS WITH TREATMENT-RESISTANT HYPERTENSION AT THE OUTPATIENT STAGE;Modern medical technology;2023-03-20

4. Association between renin–angiotensin–aldosterone system blockade and clinical outcomes in patients with hypertension: real-world observation from a nationwide hypertension cohort;Clinical Research in Cardiology;2023-03-03

5. Relationship between Awareness of Morbidity Risk and Psychosocial Wellness of Students in Public Secondary Schools in Nairobi County, Kenya;African Journal of Empirical Research;2022-11-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3